View in EDS HTML Full Text PDF Full Text

Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.

Saved in:
Bibliographic Details
Title: Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.
Authors: Ghelardi F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Raimondi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Randon G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Pannone A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Guaglio M; Peritoneal Surface Malignancies Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori di Milano, Milan, Italy., Mazzoli G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Nasca V; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Milione M; First Division of Pathology, Department of Pathology and Laboratory Medicine, Istituto Nazionale dei Tumori di Milano, Fondazione IRCCS, Milan, Italy., Leoncini G; First Division of Pathology, Department of Pathology and Laboratory Medicine, Istituto Nazionale dei Tumori di Milano, Fondazione IRCCS, Milan, Italy., Sabella G; First Division of Pathology, Department of Pathology and Laboratory Medicine, Istituto Nazionale dei Tumori di Milano, Fondazione IRCCS, Milan, Italy., Greco GF; Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy., Lampis BR; Medical Oncology Department, Ospedale San Martino, Oristano, Italy., Galassi M; Centrale Produzione Farmaci, Hospital Pharmacy, National Cancer Institute of Milan, Milan, Italy., Delfanti S; Mesothelioma and Rare Cancer Unit, Azienda Ospedaliera 'S.S. Antonio e Biagio e Cesare Arrigo', Alessandria, Italy., Nannini M; Oncology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Intini R; Department of Oncology, Veneto Institute of Oncology IRCCS, Padova, Italy., Baratti D; Peritoneal Surface Malignancies Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori di Milano, Milan, Italy., Di Bartolomeo M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Deraco M; Peritoneal Surface Malignancies Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori di Milano, Milan, Italy., Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: filippo.pietrantonio@istitutotumori.mi.it.
Source: Clinical colorectal cancer [Clin Colorectal Cancer] 2023 Dec; Vol. 22 (4), pp. 450-456.e1. Date of Electronic Publication: 2023 Aug 11.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37657955
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ghelardi+F%22">Ghelardi F</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Raimondi+A%22">Raimondi A</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Morano+F%22">Morano F</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Randon+G%22">Randon G</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Pannone+A%22">Pannone A</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Guaglio+M%22">Guaglio M</searchLink>; Peritoneal Surface Malignancies Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Mazzoli+G%22">Mazzoli G</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Nasca+V%22">Nasca V</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Milione+M%22">Milione M</searchLink>; First Division of Pathology, Department of Pathology and Laboratory Medicine, Istituto Nazionale dei Tumori di Milano, Fondazione IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Leoncini+G%22">Leoncini G</searchLink>; First Division of Pathology, Department of Pathology and Laboratory Medicine, Istituto Nazionale dei Tumori di Milano, Fondazione IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Sabella+G%22">Sabella G</searchLink>; First Division of Pathology, Department of Pathology and Laboratory Medicine, Istituto Nazionale dei Tumori di Milano, Fondazione IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Greco+GF%22">Greco GF</searchLink>; Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Lampis+BR%22">Lampis BR</searchLink>; Medical Oncology Department, Ospedale San Martino, Oristano, Italy.<br /><searchLink fieldCode="AU" term="%22Galassi+M%22">Galassi M</searchLink>; Centrale Produzione Farmaci, Hospital Pharmacy, National Cancer Institute of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Delfanti+S%22">Delfanti S</searchLink>; Mesothelioma and Rare Cancer Unit, Azienda Ospedaliera 'S.S. Antonio e Biagio e Cesare Arrigo', Alessandria, Italy.<br /><searchLink fieldCode="AU" term="%22Nannini+M%22">Nannini M</searchLink>; Oncology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Intini+R%22">Intini R</searchLink>; Department of Oncology, Veneto Institute of Oncology IRCCS, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Baratti+D%22">Baratti D</searchLink>; Peritoneal Surface Malignancies Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Di+Bartolomeo+M%22">Di Bartolomeo M</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Deraco+M%22">Deraco M</searchLink>; Peritoneal Surface Malignancies Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pietrantonio+F%22">Pietrantonio F</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: filippo.pietrantonio@istitutotumori.mi.it.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101120693%22">Clinical colorectal cancer</searchLink> [Clin Colorectal Cancer] 2023 Dec; Vol. 22 (4), pp. 450-456.e1. <i>Date of Electronic Publication: </i>2023 Aug 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101120693 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0674 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215330028%22">15330028 </searchLink><i>NLM ISO Abbreviation: </i>Clin Colorectal Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37657955
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clcc.2023.08.005
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 450
    Titles:
      – TitleFull: Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ghelardi F
      – PersonEntity:
          Name:
            NameFull: Raimondi A
      – PersonEntity:
          Name:
            NameFull: Morano F
      – PersonEntity:
          Name:
            NameFull: Randon G
      – PersonEntity:
          Name:
            NameFull: Pannone A
      – PersonEntity:
          Name:
            NameFull: Guaglio M
      – PersonEntity:
          Name:
            NameFull: Mazzoli G
      – PersonEntity:
          Name:
            NameFull: Nasca V
      – PersonEntity:
          Name:
            NameFull: Milione M
      – PersonEntity:
          Name:
            NameFull: Leoncini G
      – PersonEntity:
          Name:
            NameFull: Sabella G
      – PersonEntity:
          Name:
            NameFull: Greco GF
      – PersonEntity:
          Name:
            NameFull: Lampis BR
      – PersonEntity:
          Name:
            NameFull: Galassi M
      – PersonEntity:
          Name:
            NameFull: Delfanti S
      – PersonEntity:
          Name:
            NameFull: Nannini M
      – PersonEntity:
          Name:
            NameFull: Intini R
      – PersonEntity:
          Name:
            NameFull: Baratti D
      – PersonEntity:
          Name:
            NameFull: Di Bartolomeo M
      – PersonEntity:
          Name:
            NameFull: Deraco M
      – PersonEntity:
          Name:
            NameFull: Pietrantonio F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0674
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Clinical colorectal cancer
              Type: main
ResultId 1